- Home
- KYMR vs PAGP Comparison
KYMR vs PAGP Comparison
Compare KYMR & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- PAGP
- Stock Information
- Founded
- KYMR 2015
- PAGP 2013
- Country
- KYMR United States
- PAGP United States
- Employees
- KYMR N/A
- PAGP N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- PAGP Natural Gas Distribution
- Sector
- KYMR Health Care
- PAGP Energy
- Exchange
- KYMR Nasdaq
- PAGP Nasdaq
- Market Cap
- KYMR 3.1B
- PAGP 3.7B
- IPO Year
- KYMR 2020
- PAGP 2013
- Fundamental
- Price
- KYMR $43.51
- PAGP $18.42
- Analyst Decision
- KYMR Strong Buy
- PAGP Hold
- Analyst Count
- KYMR 15
- PAGP 8
- Target Price
- KYMR $58.53
- PAGP $20.29
- AVG Volume (30 Days)
- KYMR 722.6K
- PAGP 1.3M
- Earning Date
- KYMR 10-30-2025
- PAGP 08-08-2025
- Dividend Yield
- KYMR N/A
- PAGP 8.24%
- EPS Growth
- KYMR N/A
- PAGP N/A
- EPS
- KYMR N/A
- PAGP 0.69
- Revenue
- KYMR $44,711,000.00
- PAGP $47,796,000,000.00
- Revenue This Year
- KYMR $58.45
- PAGP N/A
- Revenue Next Year
- KYMR N/A
- PAGP $17.44
- P/E Ratio
- KYMR N/A
- PAGP $26.79
- Revenue Growth
- KYMR N/A
- PAGP N/A
- 52 Week Low
- KYMR $19.45
- PAGP $16.61
- 52 Week High
- KYMR $53.27
- PAGP $22.31
- Technical
- Relative Strength Index (RSI)
- KYMR 53.28
- PAGP 35.01
- Support Level
- KYMR $39.84
- PAGP $18.58
- Resistance Level
- KYMR $43.43
- PAGP $19.32
- Average True Range (ATR)
- KYMR 2.03
- PAGP 0.30
- MACD
- KYMR 0.15
- PAGP -0.02
- Stochastic Oscillator
- KYMR 78.76
- PAGP 16.28
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.